Stay updated on Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.

Latest updates to the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry (v3.6.4) was added to the study history, replacing the previous version (v3.6.3) and documenting an updated version of the record.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry v3.6.3 is added to the study record history, replacing the previous v3.6.2, signaling an update to the page’s version for this study record.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history. The earlier revision (v3.6.0) was removed from the visible history, updating the record's version history.SummaryDifference0.1%

- Check57 days agoChange DetectedRecruitment status was updated to not recruiting. The history now shows a new revision: v3.6.0, with the prior revision v3.5.5 removed.SummaryDifference0.4%

- Check64 days agoChange DetectedA new revision entry v3.5.5 was added to the history, and the previous revision v3.5.4 was removed from the history.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry v3.5.4 has been added to the study's record history, and the older entry v3.5.3 has been removed. This update reflects an adjustment to the visible version history of the record rather than changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.